In hepatocellular carcinoma, PLOD2 expression correlated with aggressive progression [37]; moreover, PLOD3 was found to be highly expressed in this cancer and may be a promising diagnostic biomarker [29, 38]. This evidence concerns the gene PLOD3 and cancer.